This country profile provides an overview of the Kingdom of Eswatini’s progress in reaching those in need of mass NTD treatment based on 2019 data.
*This includes all countries in Africa that are endemic for at least one of the five NTDs
Treatment coverage
Elephantiasis
N/A
Blinding trachoma
N/A
Intestinal worms
79%
Bilharzia
0%
River blindness
N/A
13k
people received treatment in Eswatini in 2019
393k
people did not receive treatment in Eswatini in 2019
Elephantiasis
Eswatini does not require mass treatment for elephantiasis.
Blinding trachoma
Eswatini does not require mass treatment for blinding trachoma.
Intestinal worms
Treatment coverage remained at 79% in 2018 and 2019.
Pre-sch and school-aged children needing treatment
17k
Pre-school and school-aged children receiving treatment
13k
Bilharzia
Treatment coverage decreased from 95% in 2018 to 0% in 2019.
School-aged children needing treatment
282k
School-aged children receiving treatment
Zero
River blindness
Eswatini does not require mass treatment for river blindness.
The 
ESPEN portal (a World Health Organization AFRO region project) provides maps and district-level data for the preventive chemotherapy diseases in eSwatini.